希少疾病用医薬品の世界市場は、2023年の2,339億ドルから2028年末までに4,152億ドルに増加し、2023年から2028年の予測期間中のCAGRは12.2%になる見込みです。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Summary
Chapter- 3: Market Overview
Market and Technology Background
Global Definitions of Rare Diseases by Country/Region
Chapter- 4: Market Dynamics
Overview
Drivers
Restraints
Opportunities
Regulatory Landscape
Chapter- 5: Global Market for Orphan Drugs by Product Type
Biological Orphan Drugs
Non-biological Orphan Drugs
Table 7 : Global Market for Orphan Drugs, by Product Type, Through 2028
Figure 4 : Global Market for Orphan Drugs, by Product Type, 2020-2028
Chapter- 6: Global Market for Orphan Drugs by Therapeutic Application
Oncology
Blood Disorders
Central Nervous System
Respiratory System
Immunomodulators
Cardiovascular Therapies
Endocrine System
Musculoskeletal System
Others
Figure 7 : Global Market Shares of Orphan Drugs, by Therapeutic Application, 2023
Chapter- 7: Global Market for Orphan Drugs by Region
Global Market Share Analysis
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter- 8: ESG Outlook in the Orphan Drugs Market
Introduction to ESG
Importance of ESG in the Orphan Drug Industry
ESG Pillars in the Orphan Drugs Industry
ESG Ratings and Metrics: Understanding the Data
ESG practices in the Orphan Drug Industry
Concluding Remarks from BCC Research
Chapter- 9: Orphan Drugs Exclusivity and Pricing Policies
Reimbursed Price of ODs: Current Strategies and Potential Improvements
Chapter- 10: Clinical Trials on Drugs for Rare Diseases
List of Clinical Trials on Drugs for Rare Diseases
Chapter- 11: Competitive Landscape
Top 10 Selling Orphan Drugs Globally
Market Share Analysis
Chapter- 12: Company Profiles
ABBVIE INC.
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BRISTOL MYERS SQUIBB
EISAI CO. LTD.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO. LTD.
Chapter- 13: Appendix: Acronyms
Acronyms
